You have ₹1,00,000 and you want to start a supplement brand, not just validate one. At this budget you can actually launch. ₹1 lakh is the balanced play: enough for one small private-label run of a low-MOQ product, a real ad budget, a subscription seed, and FSSAI plus a trademark search. It does not stretch to a full range, a hero whey tub, or a 10,000-unit order. So the whole game is discipline: one or two SKUs, and every rupee pointed at proving a specific person will buy this and buy it again.
Here is the direct answer. Spend roughly ₹40,000 on your first inventory run, ₹18,000 on FSSAI plus a trademark search and filing, ₹8,000 on your own store and compliant labels, ₹15,000 to ₹20,000 on a claims-safe ad test, and hold ₹12,000 to ₹15,000 for the first restock. Pick a gummy or vitamin range or an entry protein blend, not whey. Sell on your own store plus Amazon from day one, and build a refill offer from the first order, because in supplements the second sale is where the money is. This guide spends that ₹1 lakh line by line, with a month 1 to 3 P&L and the FSSAI and claims rules that quietly kill more brands than bad product does.
₹1 lakh funds a real, small supplement launch: 1 to 2 SKUs, private-label-light, own store plus Amazon, a subscription seed, and a ₹15,000 to ₹20,000 ad test. Allocation: ~₹40,000 inventory, ₹18,000 FSSAI plus trademark, ₹8,000 store and labels, ₹15,000 to ₹20,000 ads, ₹12,000 to ₹15,000 buffer. Pick low-MOQ formats (gummies, vitamin capsules, entry protein), never whey, which needs imported raw material and scale you do not have. From 1 April 2026 a brand under Rs 1.5 crore turnover needs only FSSAI Basic Registration, now perpetual with no annual renewal. The wedge is a narrow health need for a specific person; the engine is repeat, because wellness buyers reorder every 30 to 60 days and subscribers carry 3 to 5x the lifetime value of one-time buyers. Validate before you commit the MOQ. This is the balanced tier, bigger than the ₹50,000 validate-only play, smaller than the ₹5 lakh range build.
Why ₹1 lakh is the balanced tier, not the lean one
The market is real and growing: India's nutraceutical sector was worth around US$38.8 billion in 2025, expanding roughly 10% a year, with gummies and vitamins the fastest-moving formats for younger buyers. But market size is not your opportunity; a disciplined slice of it is. Three budgets, three different plays. See where ₹1 lakh sits before you spend a rupee of it.
| Budget | What it really is | SKUs | What you can prove |
|---|---|---|---|
| ₹50,000 | A validation test, not a launch. Positioning ad spend, a pre-book page, samples of a stock blend. Not enough to safely meet a private-label MOQ. | 0 to 1 | That a specific audience wants this at your price, before you commit inventory |
| ₹1 lakh | The balanced play. One or two SKUs at a low MOQ, a real ad test, a subscription seed, full compliance. Enough to launch, not enough to waste. | 1 to 2 | Sell-through, a repeatable CAC, and the first refills inside 90 days |
| ₹5 lakh | A range build. Two to four SKUs at real MOQs, custom packaging, a bigger ad engine, working capital for the first restock. | 2 to 4 | ₹1 lakh+ months and the base for the climb to ₹5 lakh |
The ₹50,000 play treats the whole budget as tuition and never touches a real MOQ. The ₹5 lakh play buys a range and an ad engine. ₹1 lakh sits between: you commit to inventory, but only just. If you are still weighing supplements against other options at this budget, the wider comparison is in I have ₹1 lakh, what business should I start. This guide assumes you have picked supplements, and it builds on the full how to start a supplement brand in India flagship, so read that for the deep manufacturing and compliance detail. Here we spend the ₹1 lakh.
The ₹1,00,000 allocation, line by line
This budget assumes a low-MOQ format and a light private-label spec: your label and your box on a proven stock formulation, not a custom recipe you paid to develop.
| Line | Amount | What it covers |
|---|---|---|
| First inventory run | ₹40,000 | One or two SKUs at a low MOQ (500 to 1,000 units per SKU from a contract nutraceutical unit): fill, packaging, inward freight. The biggest line, and the one to keep small. |
| FSSAI + trademark | ₹18,000 | FSSAI Basic Registration (small fee, now perpetual), a Class 5 trademark search, and the filing (Rs 4,500 government fee plus agent cost). |
| Store + labels | ₹8,000 | Shopify or equivalent for a year on the entry plan, a clean theme, and Legal Metrology compliant label design and printing. |
| Ad validation test | ₹15,000 to ₹20,000 | A claims-safe Meta and Google test to find a repeatable CAC before you scale spend or reorder. |
| Restock buffer | ₹12,000 to ₹15,000 | Cash held back for the first reorder. Founders who spend this on launch day run out of stock right when ads start working. |
Notice what is missing: custom formulation, custom-mould gummies, influencers, a designer, a big Amazon ad spend. None of it survives a ₹1 lakh budget, and none of it is needed to prove the business. The classic mistake is buying more inventory because the per-unit price drops at the next slab. At ₹1 lakh, more boxes is the fastest way to zero. The route logic behind this light private-label choice is in white label vs private label vs OEM in India.
If you have no audience and no proof yet → order the smallest first batch you can, run the ad test, and reorder only against real sell-through. If you already have an audience (a gym, a clinic, a nutritionist practice, an Instagram following) → commit the ₹40,000 inventory line up front, because your first sales are warm. If a unit will only sell you 5,000+ units → walk; at ₹1 lakh you need a partner that quotes 500 to 1,000, not one that needs you to fund their factory. If any part of this needs borrowing → drop to the ₹50,000 validate-only play first.
Pick the product: gummies, vitamins, or entry protein, not whey
At ₹1 lakh your product is decided by MOQ and margin, not by what looks biggest. Three formats fit. Vitamin and targeted capsules (biotin, omega, joint support, a women's multivitamin) carry the lowest MOQ, often 500 to 1,000 units, land at ₹90 to ₹200 including packaging, and sell at ₹499 to ₹899, the cleanest ₹1 lakh entry. Gummies are the format millennials and Gen-Z want because they are tired of pills, at ₹499 to ₹799, but they cook in labour-heavy batches, so MOQs run higher; do them only if you find a low-MOQ or shared-batch unit, otherwise add them at the ₹5 lakh tier. An entry plant protein or blended powder pouch, ₹899 to ₹1,499, works if a unit will do a small batch, and its inputs are largely Indian and rupee-priced, so the margin holds.
Whey is the trap: imported dollar-priced raw material drags margins to 25 to 40%, the gym buyer compares price-per-gram and ignores new brands, and a known fakes problem poisons trust before you arrive. ₹1 lakh in whey buys a price war you lose; the same money in a targeted capsule or gummy buys a 65% margin and a buyer who pays for the outcome (the full breakdown is in the category flagship). Whatever you pick, write the wedge as one sentence: which health need, for which specific person, in which format. "Sleep gummies for stressed desk workers." If it is "protein for gym-goers," you have a price war, not a brand.
Own store plus Amazon, and a subscription from order one
You sell in two places, and you set up the third thing, the refill, before your first customer.
Your own store. Home base, and the only place you fully own the customer, run subscription and multi-month packs, and control your claims copy. The refill flow lives here, and it is the actual business model in supplements.
Amazon. Supplement buyers search Amazon by ingredient ("biotin tablets," "ashwagandha gummies"), so there is demand you do not pay to create, plus trust for an unknown brand. It takes 25 to 35% of MRP in fees and gives you no customer data, so use it to harvest search demand, then convert repeat buyers to your store with a pack insert offering a better refill price. The full platform trade-offs are in Amazon vs Shopify in India.
The subscription seed. This is the ₹1 lakh move most founders skip and later regret. A 60-count bottle empties on a schedule and wellness buyers reorder every 30 to 60 days, so from your first order offer "subscribe and save" plus a two- or three-month pack. A subscriber carries 3 to 5x the lifetime value of a one-time buyer, with that refill arriving at near-zero cost. Few will subscribe in month one, but the flow must exist so it can compound, using the mechanics in the subscription D2C business guide for India.
Margin Waterfall™: selling price minus COGS, packaging, shipping, payment gateway, RTO loss, then CAC. If the number at the bottom is negative, no amount of scale saves it. In non-whey supplements the waterfall survives the top four lines comfortably, because product margin is generous. It lives or dies at CAC, which runs high because the claims rules force you to advertise with one hand tied. According to the Margin Waterfall™ framework, contribution margin is calculated before the ad budget is set, not found out after it has spent.
₹141 on a ₹699 first sale is thin, and the fragile line is CAC. Because you cannot make the punchy disease claims that convert cold traffic cheaply, supplement CAC starts high, often ₹250 to ₹400 for a new brand, so the first order barely pays for itself. The whole ₹1 lakh bet is that the second order does not cost ₹250 to win: a refill at near-zero CAC turns that customer into ₹400+ of contribution and a subscriber into ₹1,000+. That is why the subscription seed is the plan, not a nice-to-have. Price with the waterfall, not a competitor's MRP, using how to price a product in India.
Month 1 to 3 P&L: what ₹1 lakh actually does
A realistic three-month view for a single-SKU launch that clears its ad test. The numbers are deliberately modest, a disciplined start, not a hockey stick.
| Line | Month 1 | Month 2 | Month 3 |
|---|---|---|---|
| Orders | 15 to 25 (test) | 40 to 60 | 70 to 100 |
| Revenue (AOV ₹699 to ₹799) | ₹12,000 to ₹18,000 | ₹30,000 to ₹45,000 | ₹55,000 to ₹78,000 |
| Ad spend | ₹8,000 to ₹10,000 | ₹7,000 to ₹10,000 | ₹8,000 to ₹12,000 |
| Refill / subscription share | ~0% | 5 to 10% | 15 to 25% |
| Owner's take-home | Negative (setup + test) | Roughly breakeven | ₹8,000 to ₹18,000 |
The shape matters more than the exact figures. Month 1 you lose money buying setup and data, month 2 you near breakeven as CAC settles and the first refills trickle in, month 3 you take a small profit and the refill share is climbing, which is the signal the model works. If by month 3 nobody is reordering, you have a one-time product, not a brand, and no ad budget fixes that. Watch the refill line, not the revenue line. The climb from here is mapped in the roadmap to ₹1 lakh a month.
In my supply chain years at Atomberg, the number I watched hardest was dead stock. Supplement founders meet a nastier version, because the box has an expiry date and a shrinking selling window. A capsule batch might carry 18 to 24 months of shelf life, but Amazon wants 70 to 75% of that remaining at inward, so your real selling window on a run is closer to six months. At ₹1 lakh this is a gift: a 500 to 1,000 unit order sells through before the clock bites, and you reorder against proven demand. The founder who "saved" ₹30,000 by ordering 5,000 units instead of 1,000 is the one dumping near-expiry stock at 60% off a year later. At this budget, small orders are not caution. They are the strategy.
FSSAI and labels: lighter than you have been told
Supplements are food under Indian law, governed by the Food Safety and Standards Authority of India (FSSAI), and here is the part most old guides get wrong for a ₹1 lakh brand. As of 1 April 2026, FSSAI raised its thresholds: a business with turnover up to Rs 1.5 crore now needs only Basic Registration, not the more expensive Central License, and registrations are now perpetual, with no annual renewal. A first-year ₹1 lakh brand sits far below Rs 1.5 crore, so you take Basic Registration through the FoSCoS portal, a genuine saving versus what older nutraceutical guides describe.
Two things to keep straight. If a contract unit makes your product, that unit holds its own manufacturing licence and you register as the brand owner and marketer, so get a copy of the unit's FSSAI licence, its GMP certificate, and a Certificate of Analysis per batch before you pay. And every ingredient must sit inside the FSSAI approved schedule; an actives outside the list needs a separate approval, so have the unit confirm the whole formula is compliant in writing. The general walkthrough is in the FSSAI license guide for India.
Your label is a delisting risk if wrong. Under the Legal Metrology (Packaged Commodities) Rules, every pack must show marketer and manufacturer name and address, net quantity, MRP inclusive of taxes, month and year of manufacture, expiry or best-before, batch number, ingredient list, the FSSAI logo and licence number, the veg or non-veg mark, and consumer care contact. Nutraceutical labels must also carry the advisory that the product is not for medicinal use, with the recommended daily dose and a warning not to exceed it. Budget ₹8,000 to design and print it right the first time.
Claims: the thing that actually kills supplement brands
Read this twice. At ₹1 lakh, a restricted ad account does not just cost a campaign, it can freeze the whole launch while your stock's expiry clock runs. The product is usually fine; the claim is not.
The law first: a supplement is not a drug, so you cannot claim it treats, cures, prevents or reduces the risk of any disease. "Cures PCOS," "reverses diabetes" and "treats anxiety" are all disallowed, and the label must state the product is not for treating disease. The ad platforms go stricter. As of 2026, Meta's Health and Wellness policy requires supplement ads to carry the not-intended-to-diagnose-treat-cure-or-prevent disclaimer in the ad copy itself and auto-rejects ads that miss it. Meta also bans before-and-after imagery and, in 2026, extends that to "implied transformations," so even placing your product beside a fit, healthy person can trip the classifier, and it restricts personal-attribute language that implies it knows the viewer's condition. Google's health policy is similar, and repeated violations restrict the whole account.
What you can say safely: name the ingredient and its recognised nutritional role ("contains vitamin D3 and K2"), keep structure-function language general and non-disease ("supports everyday energy"), sell format and taste, and use honest customer-experience language. When in doubt, sell the ingredient and the person, not the cure, and put the disclaimer in the copy.
Ordering the inventory before testing whether you can advertise it. A founder puts ₹40,000 of their ₹1 lakh into 1,000 bottles of a genuinely good ashwagandha sleep blend, then writes the honest, human ad: "Beat your anxiety and sleep through the night." True to them, a disease-and-personal-attribute claim to Meta. The ad is rejected, they resubmit, the account picks up strikes, and by the time they learn the rules it is restricted, the ₹15,000 ad budget is stuck, and 1,000 bottles sit with the shelf-life clock ticking. At ₹1 lakh you cannot absorb that. Write the compliant ad angle first, confirm a small test clears review, then commit the inventory.
When to file the trademark: the search now, the filing early
The honest answer at ₹1 lakh: do the search now, file as early as the budget allows, never skip the search. Founders waste money in both directions.
The search is nearly free and non-negotiable. Before you print a single label, run a public trademark search in Class 5 (nutritional supplements) to confirm nobody already owns your name. Skip it and you can build a brand on Amazon, get traction, then take a cease-and-desist and lose the name, the listings and the reviews. Filing costs Rs 4,500 in government fee for an individual, MSME or DPIIT-recognised startup (Rs 9,000 for others) plus any agent fee, fits inside the ₹18,000 line, and gives you a priority date and the right to use the ™ symbol. If month-one cash is tight, the acceptable compromise is to search now, pick a clearly available name, start selling, and file within two to three months from revenue. Building without the search is never acceptable: a name you cannot own is inventory with a deadline.
Validation Sprint™: a tight pre-launch test that answers, in two to three weeks and for a few thousand rupees, whether a specific audience wants this product at your price, before you commit the MOQ. In supplements the sprint carries a second question most founders miss: can you legally advertise it? So it runs a claims-safe ad to a pre-book or email-capture page, and it passes only if both the demand signal and the ad approval come back green. According to the Validation Sprint™, you never fund a 1,000-unit run on a hunch, you fund it on a signal you paid a little to confirm.
The full method for reading a test honestly, so you do not talk yourself into a launch the numbers do not support, is in how to validate a business idea.
The upgrade path: from ₹1 lakh to a real range
₹1 lakh is a starting line, not a ceiling. Once your first product shows a 20%+ repeat rate and a CAC you can live with, the profit and refill revenue fund SKU two, ideally a format your buyers already asked for, so you extend a proven audience instead of guessing. Layer a small Amazon ad budget only once reviews build and the listing already converts. Then, consistently near ₹1 lakh a month, move to the range-and-engine build, 2 to 4 SKUs at proper MOQs and an always-on ad budget, mapped in the roadmap to ₹5 lakh a month. Founders who jump straight to a ₹5 lakh inventory spend before proving repeat usually buy a warehouse of stock the market never asked for.
Execution checklist
- Write your wedge in one sentence: which health need, for which specific person, in which format. If it is "protein for gym-goers," rewrite it.
- Write the compliant ad angle first, with the not-intended-to-treat disclaimer, and confirm a small test clears Meta and Google review before you order stock.
- Run a Class 5 trademark search before printing anything. File now if the ₹18,000 line allows, or within two to three months from revenue.
- Pick a low-MOQ format (vitamin capsules easiest, gummies if you find a low-MOQ unit, entry plant protein). Never whey at this budget.
- Get three quotes plus FSSAI licence copy, GMP certificate and a per-batch COA from contract units that will do 500 to 1,000 units.
- Confirm in writing that every ingredient sits inside the FSSAI approved schedule.
- Take FSSAI Basic Registration on FoSCoS (Rs 1.5 crore threshold, perpetual, no renewal) and register GST before you list anywhere.
- Build the label against the full Legal Metrology list plus the non-medicinal advisory, and print it right the first time.
- Launch on your own store plus Amazon, and switch on subscribe-and-save and a two-month pack from order one.
- Hold back ₹12,000 to ₹15,000 for the first restock, and reorder only against sell-through, never against a per-unit discount.
Your next action
Today, do three things in order. Write your wedge sentence, the specific person and the specific health need. Draft the ad you would actually run, add the not-intended-to-treat disclaimer, and read it against Meta's policy, marking any line that claims to treat, cure or prevent. Then run a public Class 5 trademark search on the name. If the wedge is sharp, the ad is clean, and the name is free, you are ready to get quotes for a 500 to 1,000 unit run and spend the ₹1 lakh properly. If any of the three is shaky, fix it now, while it is cheap. The frameworks in this guide come from Ravikant Tyagi's operating system built for exactly this journey.
If you'd like the complete execution system, calculators, SOPs, templates and operating frameworks behind this process, continue inside D2C Acquisition.Lab.
